Analyst Ratings:
Today’s analyst ratings show a strong bullish bias, with numerous upgrades and initiations to “Buy” or equivalent ratings across a diverse set of sectors. Companies like Amazon, Autodesk, Elastic, and The Boeing Company received favorable upgrades, while firms such as Core Scientific, CRISPR Therapeutics, and ProQR Therapeutics had their positive ratings reiterated. Financial and real estate names like EMCOR Group and Affiliated Managers also saw increased analyst confidence. However, there were some cautious signals, with downgrades issued for companies like JPMorgan, Molson Coors, and TAL Education, and “Hold” ratings reaffirmed for Lyft and Uber. Overall, the updates for today reflect widespread optimism, especially in tech, healthcare, and industrials:
36Kr Holdings (KRKR) had its Sell rating reiterated by Weiss Ratings.
A10 Networks, Inc. (ATEN) was initiated with a Buy rating by Deutsche Bank, with a price target of $22.00.
Acushnet (GOLF) had its target raised by KeyCorp to Overweight, with a price target raised to $80.00.
Affiliated Managers Group, Inc. (AMG) was upgraded by Goldman Sachs to Buy from Neutral, with a price target of $218.00.
AllianceBernstein Holding L.P. (AB) was downgraded by Goldman Sachs to Neutral from Buy, with a price target of $40.00.
Alphabet (GOOGL) was upgraded by Citizens JMP to Outperform, with a price target of $220.00.
Alphabet (GOOGL) was downgraded by BNP Paribas Exane to Neutral, with a price target of $172.00.
Alphabet (GOOGL) was upgraded by JMP Securities to Market Outperform, with a price target of $220.00.
Altimmune, Inc. (ALT) had its Buy rating reiterated by HC Wainwright, with a price target of $12.00.
Amazon.com, Inc. (AMZN) was upgraded by BNP Paribas Exane to Outperform from Neutral, with a price target of $254.00.
Armada Hoffler Properties, Inc. (AHH) was initiated with a Buy rating by Jefferies Financial Group, with a price target of $8.00.
Avidity Biosciences, Inc. (RNA) had its Overweight rating reiterated by Cantor Fitzgerald, with a price target of $96.00.
Autodesk, Inc. (ADSK) was upgraded by Berenberg Bank to Buy from Hold, with a price target of $365.00.
Bank of America Corporation (BAC) was downgraded by Robert W. Baird to Neutral from Outperform, with a price target of $52.00.
The Boeing Company (BA) was upgraded by Rothschild & Co Redburn to Buy from Neutral, with a price target of $275.00.
Compass (COMP) was initiated with a Buy rating by BTIG Research, with a price target of $9.00.
Constellation Brands Inc (STZ) had its target set by Goldman Sachs with a Buy rating, at a price target of $225.00.
Core Scientific (CORZ) had its Buy rating reiterated by Canaccord Genuity Group, with a price target of $17.00.
Core Scientific (CORZ) also had its Buy rating reiterated by Needham & Company LLC, with a price target of $18.00.
Crinetics Pharmaceuticals (CRNX) had its Buy rating reiterated by HC Wainwright, with a price target of $81.00.
CRISPR Therapeutics (CRSP) had its Buy rating reiterated by HC Wainwright, with a price target of $65.00.
CRISPR Therapeutics (CRSP) also had its Market Outperform rating reiterated by JMP Securities, with a price target of $86.00.
Elastic (ESTC) was upgraded by Monness Crespi & Hardt to Buy, with a price target of $111.00.
EMCOR Group (EME) was initiated with an Outperform rating by Robert W. Baird, with a price target of $560.00.
Estee Lauder Companies (EL) was upgraded by HSBC to Buy, with no price target provided.
First Financial Bancorp (FFBC) had its Overweight rating reiterated by Stephens, with a price target of $29.00.
Fortis (FTS) was initiated with a Buy rating by TD Securities.
Franklin Resources, Inc. (BEN) was upgraded by Goldman Sachs to Buy from Neutral, with a price target of $29.00.
HIVE Digital Technologies (HIVE) had its target lowered by Rosenblatt Securities but maintained a Buy rating, with a price target of $5.00.
HIVE Digital Technologies (HIVE) had its target lowered by HC Wainwright but maintained a Buy rating, with a price target of $6.00.
HIVE Digital Technologies (HIVE) had its target raised by Cantor Fitzgerald to Overweight, with a price target of $5.50.
I-Mab (IMAB) had its target raised by Needham & Company LLC to Buy, with a price target of $5.00.
James Hardie Industries (JHX) was initiated with an Outperform rating by William Blair, with no price target provided.
JPMorgan Chase & Co. (JPM) was downgraded by Robert W. Baird to Underperform, with a price target of $235.00.
Lyft (LYFT) had its Hold rating reiterated by Canaccord Genuity Group, with a price target of $14.00.
Lyft (LYFT) had its Hold rating reiterated by Citigroup, with a price target of $14.00.
Molson Coors Beverage Company (TAP) was downgraded by Bank of America to Neutral from Buy, with a price target of $50.00.
New Oriental Education (EDU) was upgraded by Citigroup to Buy, with a price target of $50.00.
NIKE (NKE) had its Market Perform rating reiterated by Telsey Advisory Group, with a price target of $70.00.
NIKE (NKE) had its target raised by Needham & Company LLC to Buy, with a price target raised to $78.00.
NIKE (NKE) was upgraded by HSBC to Buy, with a price target of $80.00.
Opus Genetics (IRD) had its Buy rating reiterated by HC Wainwright, with a price target of $8.00.
Orion Energy Systems, Inc. (OESX) had its target lowered by H.C. Wainwright but maintained a Buy rating, with a price target of $2.00.
Progress Software Corporation (PRGS) had its Buy rating reiterated by Guggenheim, with a price target of $83.00.
Progress Software Corporation (PRGS) had its Neutral rating reiterated by Citigroup.
Progress Software Corporation (PRGS) had its Outperform rating reiterated by Wedbush, with a price target of $75.00.
Progress Software Corporation (PRGS) had its Hold rating reiterated by Jefferies, with no price target provided.
ProQR Therapeutics N.V. (PRQR) had its Market Outperform rating reiterated by JMP Securities, with a price target of $8.00.
ProQR Therapeutics N.V. (PRQR) had its Overweight rating reiterated by Cantor Fitzgerald, with a price target of $8.00.
Republic Bancorp, Inc. (RBCAA) was initiated with a Market Perform rating by Raymond James, with no price target provided.
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had its Buy rating reiterated by D. Boral Capital, with a price target of $3.00.
S&T Bancorp, Inc. (STBA) was initiated with a Market Perform rating by Hovde Group, with a price target of $41.00.
Sprinklr (CXM) had its Market Outperform rating reiterated by JMP Securities, with a price target of $17.00.
TAL Education Group (TAL) was downgraded by Citigroup to Neutral from Buy, with a price target of $11.54.
The Trade Desk (TTD) was upgraded by Evercore ISI to Outperform from In-Line, with a price target of $90.00.
Uber Technologies, Inc. (UBER) had its Hold (from Buy) rating reiterated by Canaccord Genuity, with a price target of $84.00.
W.R. Berkley Corporation (WRB) was downgraded by TD Cowen to Hold from Buy, with a price target of $78.00.
WisdomTree, Inc. (WT) was upgraded by Goldman Sachs to Neutral from Sell, with a price target of $11.90.
XPO, Inc. (XPO) had its target lowered by TD Cowen but maintained a Buy rating, with a price target of $133.00.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
Interesting to see such a strong bullish trend across tech and healthcare, especially with upgrades for Amazon and CRISPR Therapeutics. The downgrade of JPMorgan amidst broader optimism also stands out—could signal sector-specific caution despite market-wide enthusiasm.